Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are engineered, stable, cyclic peptides with very low immunogenicity and toxicity. They modulate pathologic inflammation and have proven effective in animal models of autoimmune and chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. They have proven effective in preclinical cancer models and augment natural host defense, functioning as host-directed anti-infectives against drug resistant pathogens.
View Top Employees from ORYN THERAPEUTICS, Inc.| Website | http://oryntherapeutics.com |
| Revenue | $608000 |
| Employees | 12 (8 on RocketReach) |
| Founded | 2008 |
| Address | 303 Twin Dolphin Dr Suite 600 # 1320, Redwood City, California 94065, US |
| Phone | (530) 219-5828 |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular ORYN THERAPEUTICS, Inc. employee's phone or email?
ORYN THERAPEUTICS, Inc. Questions
The ORYN THERAPEUTICS, Inc. annual revenue was $608000 in 2024.
Shyamal Das is the Vice President Clinical Development of ORYN THERAPEUTICS, Inc..
8 people are employed at ORYN THERAPEUTICS, Inc..
ORYN THERAPEUTICS, Inc. is based in Redwood City, California.
The NAICS codes for ORYN THERAPEUTICS, Inc. are [54171, 541, 54, 5417, 541714].
The SIC codes for ORYN THERAPEUTICS, Inc. are [873, 87].
Top ORYN THERAPEUTICS, Inc. Employees
-
42
-
1
-
1
-
34
-
ViewAfrodite Lourbakos
Senior Director Translational Medicine at ORYN THERAPEUTICS, Inc.
California, United States1 -
5+5+
-
45+
-
21
Related Companies
